EIM
AXSM icon

Essex Investment Management’s Axsome Therapeutics AXSM Stock Holding History

Essex Investment Management’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.76M Sell
16,328
-1,053
-6% -$182K 0.44% 90
2025
Q4 		$3.17M Buy
17,381
+17,064
+5,383% +$2.38M 0.48% 79
2025
Q3 		$38.5K Buy
+317
New +$35.7K 0.01% 261
2020
Q1 		– Sell
-20,000
Closed -$2.07M – 394
2019
Q4 		$2.07M Buy
+20,000
New +$808K 0.25% 129

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Investment Management's AXSM Position: Q1 2026 in Review

Essex Investment Management reduced its Axsome Therapeutics (AXSM) stake by 6.1% in Q1 2026, selling an estimated $182K and leaving 16,328 shares worth $2.76M. The position accounts for 0.44% of the portfolio, ranked #90.

Essex Investment Management first reported a position in AXSM in Q4 2019 and has held it in 4 quarters since. The position peaked at $3.17M in Q4 2025. 409 funds tracked by Wall St. Rank hold AXSM as of Q1 2026.

  • Essex Investment Management held 16,328 shares of Axsome Therapeutics worth $2.76M as of Q1 2026.
  • Essex Investment Management sold 1,053 Axsome Therapeutics shares in Q1 2026, an estimated $182K.
  • Axsome Therapeutics made up 0.44% of Essex Investment Management's portfolio in Q1 2026, its #90 holding.
  • Essex Investment Management first reported a position in Axsome Therapeutics in Q4 2019 and has held it in 4 quarters since.
  • Essex Investment Management's Axsome Therapeutics position peaked at $3.17M in Q4 2025.
  • 409 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q1 2026.

Based on Essex Investment Management's 13F filing for Q1 2026, filed 11 May 2026.